Key Highlights

  • Core Energy Minerals (ASX:CR3) announced on 4 September 2026 firm commitments for a placement at $0.006 per share raising $3.025 million before costs.
  • A substantial shareholder will invest $1 million, lifting his holding to 19.7%, and directors have committed $100,000 in total, subject to shareholder approval.
  • Proceeds will fund exploration and delineation of a maiden JORC resource at the Nova Uranium Project in Namibia, and general working capital.

Core Energy Minerals Limited (ASX:CR3) announced on 4 September 2026 firm commitments for a capital raising of $3.025 million through a two-tranche placement at $0.006 per share. The funds are directed to the Nova Uranium joint venture in Namibia.

This article describes the company, the sector context, the placement and the factors that may influence the company.

About Core Energy Minerals

Core Energy Minerals Ltd is an ASX-listed critical minerals exploration company with an office in West Leederville, Western Australia. It describes a critical minerals and uranium asset portfolio across Brazil, Australia and Southern Africa, with a current focus on rare earth elements and uranium.

The announcement refers to district-scale tenure in Namibia's Erongo uranium province and the Nova Uranium Project, for which the company plans to delineate a maiden JORC Resource. Core Energy does not report production revenue.

Sector backdrop

Namibia's Erongo region hosts uranium mines and exploration projects, and small explorers fund work through placements, often combined with attaching options. Placements at low share prices involve large numbers of shares, so share counts can increase materially.

Under ASX Listing Rules, companies can issue a limited proportion of capital without shareholder approval under Listing Rules 7.1 and 7.1A, and issues to directors require approval under Listing Rule 10.11.

Two-tranche placements commonly issue an unconditional first tranche immediately and a second tranche that depends on shareholder approval.

Placement announced on 4 September 2026

Structure and price

The placement is of up to about 504 million shares at $0.006 per share, to raise $3.025 million before costs, to institutional, professional and sophisticated investors. Tranche 1 is an unconditional placement of up to 178.08 million shares, with 106,850,000 shares issued under the company's Listing Rule 7.1 capacity and 71,235,000 shares under its Listing Rule 7.1A capacity. Tranche 2 is a conditional placement of up to 326,081,667 shares subject to shareholder approval. The issue price is a 25% discount to the last price of $0.008 and an 18% discount to the 15-day VWAP.

Subject to shareholder approval, each share issued will carry one free-attaching unlisted option for every three shares, with an exercise price of $0.011 and an expiry three years from issue. The company will issue a notice of meeting in the coming weeks to approve the Tranche 2 shares, the options, director participation and broker options. Tranche 1 shares are expected to be issued on or around 11 September 2026.

Participants and use of funds

A substantial shareholder, who is the founder and president of an international investment firm, will invest $1 million to take his holding to 19.7%. Three directors have committed $50,000, $30,000 and $20,000 respectively, subject to approval under Listing Rule 10.11. Proceeds will fund the Nova Uranium Project joint venture, including delineation of a maiden JORC Resource, general working capital and the costs of the capital raising. The company says it is funded to accelerate on-ground exploration, with field work commencing immediately.

The announcement lists broker options that are also subject to shareholder approval, and states that placement shares will rank equally with existing ordinary shares. The placement is made under section 708 of the Corporations Act to institutional, professional and sophisticated investors. The company said it expects to issue Tranche 1 shares on or around 11 September 2026, and that it will issue a notice of general meeting in the coming weeks to approve the Tranche 2 shares, options, director participation and broker options.

Core growth drivers and material operating risks

Core growth drivers

The items identified are the shareholder meeting to approve Tranche 2, field work at Nova, delineation of a maiden JORC Resource and progress at the company's Namibian tenure.

Material operating risks

Tranche 2, the attaching options and director participation need shareholder approval, so about two-thirds of the shares are conditional. Issuing about 504 million shares increases shares on issue. No resource exists at Nova yet, and a maiden JORC Resource depends on drilling results. Exploration in Namibia carries licensing and logistical factors, and further funding may be needed.